rosiglitazone has been researched along with dihydrotestosterone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gege, C; Hoffmann, T; Schlüter, T | 1 |
| Ciletti, N; Deplewski, D; Kentsis, A; Rosenfield, RL | 1 |
| Nowotny, P; Vierhapper, H; Waldhäusl, W | 1 |
| Lyles, BE; Moss, PE; Stewart, LV | 1 |
4 other study(ies) available for rosiglitazone and dihydrotestosterone
| Article | Year |
|---|---|
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
Topics: Benzeneacetamides; Drug Inverse Agonism; Fluorescence Resonance Energy Transfer; Humans; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 2; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Th17 Cells; Thiazoles; Tretinoin | 2014 |
Mechanisms of androgen induction of sebocyte differentiation.
Topics: Androgens; Animals; Cell Differentiation; Cells, Cultured; Dihydrotestosterone; Linoleic Acid; Lipids; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sebaceous Glands; Thiazoles; Thiazolidinediones; Transcription Factors | 1998 |
Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone.
Topics: Adult; Dihydrotestosterone; Humans; Hydrocortisone; Male; Random Allocation; Reference Values; Rosiglitazone; Steroids; Testosterone; Thiazoles; Thiazolidinediones | 2003 |
The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Topics: Androgen-Binding Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dihydrotestosterone; Gene Expression; Genes, Reporter; Humans; Hypoglycemic Agents; Male; Mutation; Neoplasms, Hormone-Dependent; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transfection | 2010 |